Skip to main content

Table 4 Benefits and drug costs over 1-year to a practice population of 10,000 resulting from the introduction of these treatments assuming the incremental benefit of the drugs

From: Implementing guidelines in primary care: can population impact measures help?

   Number Needed to Treat (NNT) Number to be Treated in your Population (NTP) Number of Events Prevented in your Population (NEPP) Total drug cost (€) Drug cost per death prevented (€)
MI       
  ACE-I 69 53 0.76 5,292 6,944
  BB 48 84 1.74 3,793 2,174
  Statin 53 120 2.26 46,150 20,423
  Aspirin 93 37 0.40 410 1,019
MI + CHF       
  ACE-I 23 3 0.15 336 2,299
  BB 16 9 0.55 406 739
  Spironolactone 11 12 1.00 1,663 1,655
  1. MI myocardial Infarction CHF Heart Failure ACE-I ACE Inhibitor BB beta blocker